The Anglo-Swedish pharmaceutical company has developed one of the vaccines against the coronavirus
Anglo-Swedish drugmaker AstraZeneca, which has developed one of the coronavirus vaccines, made a net profit of 2,592 million euros (3,144 million dollars) in 2020, 159% more than the previous year.
In a statement sent this Thursday to the London Stock Exchange, the company indicated that its profit before taxes stood at 3,228 million euros (3,916 million dollars), an increase of 152% compared to the year previous.
Total revenues in 2020 reached 21,945 million euros (26,617 million dollars), an increase of 9.1% compared to 2019, added the company, which has highlighted the significant income generated for the rapid development of new drugs, as well as the advances to produce the vaccine against Covid-19.
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
